Paper
Paper
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
Endowment
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Efficacy and safety of olomorasib (LY3537982), a second-g...
Efficacy and safety of olomorasib (LY3537982), a second-generation KRAS G12C inhibitor (G12Ci), in combination with pembrolizumab in patients with KRAS G12C-mutant advanced NSCLC.
By
Timothy Burns
19 more
Timothy Burns
·
Yutaka Fujiwara
17 more
·
Natraj Ammakkanavar
June 1, 2024
0
Paper
Reviews
0
Conversation
0
Bounties
0
Paper
Paper
Search
Search
Ctrl+K
Publish
Home
Fund
Earn
Journal
Notebook
Lists
Endowment
RSC
USD
About
Docs
Changelog
Terms
Privacy
Support
Sign in to write a comment…
Best
Journal
Journal of Clinical Oncology
Topics
#biology
#biochemistry
#medicine
#cancer-biology
#internal-medicine
Show all topics
DOI
10.1200/jco.2024.42.16_suppl.8510
